Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares rose 5.1% to $2.26. Eisai and Arena Pharma reported the Food and Drug Administration acceptance of NDA for ER formulation of Lorcaserin. Share volume totaled one million, compared to an all-day average of 2.9 million
